About
Device for Depression Treatment
Areas of Focus
Categories
Uncategorized Medical DeviceBiotech
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
4
As Collaborator
2
Total Enrollment
1,246
By Phase
NA: 3PHASE2/PHASE3: 2
By Status
TERMINATED: 2NOT_YET_RECRUITING: 1RECRUITING: 1ACTIVE_NOT_RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT07210255Lead Sponsor
SAINT in Postpartum Depression (PPD)
NANot yet recruiting
192 participants
Started: Nov 1, 2025 · Completed: Oct 31, 2029
NCT06523439Collaborator
Accelerated Intermittent Theta Burst in Treatment-Naive Adolescents
NARecruiting
40 participants
Started: Jan 31, 2025 · Completed: Sep 30, 2026
NCT03693105Lead Sponsor
The Effects of SAINT® Neuromodulation System on Explicit and Implicit Suicidal Cognition
PHASE2/PHASE3Terminated
2 participants
Started: Jun 30, 2024 · Completed: Mar 6, 2025
NCT06462820Lead Sponsor
SAINT for MDD in an Inpatient Setting Follow-on
PHASE2/PHASE3Terminated
2 participants
Started: Jun 30, 2024 · Completed: Mar 6, 2025
NCT05819021Lead Sponsor
Open Label Optimization Study
N/AActive, not recruiting
1,000 participants
Started: Apr 6, 2023 · Completed: Apr 15, 2027
Locations (1)
Headquarters
Burlingame, CA, United States
Map
Loading map...